Clinical Features and Prognostic Outcomes in Patients with Ocular Syphilis and HIV Co-Infection - Report - MDSpire

Clinical Features and Prognostic Outcomes in Patients with Ocular Syphilis and HIV Co-Infection

  • By

  • Wenjun Kong

  • Fang Ruan

  • Lianyong Xie

  • Xia Feng

  • Yanqing Gao

  • Zhuyun Qian

  • Yong Tao

  • November 19, 2025

  • 0 min

Share

Clinical Features and Prognostic Outcomes in Ocular Syphilis with HIV Co-Infection

Overview

This study evaluated 31 patients with ocular syphilis and HIV co-infection, focusing on ocular manifestations and visual prognosis. Significant improvement in visual acuity was observed after standard anti-syphilitic treatment, with optic neuritis cases showing the poorest baseline and final vision.

Background

Syphilis, known as the 'great imitator,' can affect multiple organs including the eyes, presenting with diverse manifestations such as uveitis and optic retinitis. The incidence of ocular syphilis has risen alongside syphilis cases since 2014, often co-existing with HIV due to shared transmission routes. Ocular syphilis diagnosis and prognosis are challenging due to variable clinical presentations. This study investigates ocular subtypes and visual outcomes in patients co-infected with HIV.

Data Highlights

CharacteristicValue
Number of patients31
Number of eyes involved42
Male predominance87.1%
Patients under 40 years23
On HAART93.5%
Median baseline CD4+ T cells132 cells/µl (IQR: 79–319)
Baseline mean LogMAR BCVA1.08 ± 0.66
Post-treatment mean LogMAR BCVA0.86 ± 0.69 (P = 0.000)
Ocular manifestation subgroupsAcute syphilitic posterior placoid chorioretinitis (13 eyes), Confluent syphilitic retinochoroiditis (12 eyes), Retinal vasculitis (4 eyes), Optic neuritis (13 eyes)
Vitreous opacity prevalence88.1%
Macular involvement prevalence69.0%

Key Findings

  • All eyes had posterior segment involvement; mild anterior uveitis was present in 11 eyes, with no episcleritis or scleritis observed.
  • Significant improvement in mean LogMAR BCVA was noted after treatment (from 1.08 to 0.86, P=0.000).
  • Four ocular manifestation subgroups were identified: acute syphilitic posterior placoid chorioretinitis, confluent syphilitic retinochoroiditis, retinal vasculitis, and optic neuritis.
  • Eyes with optic neuritis had the worst baseline and final visual acuity compared to other subgroups (P<0.05).
  • Vitreous opacity was present in 88.1% of eyes, with no significant difference among subgroups.
  • Macular involvement was found in 69.0% of eyes but was significantly less frequent in eyes with optic neuritis (P<0.05).

Clinical Implications

Clinicians should be aware that ocular syphilis in HIV co-infected patients predominantly affects the posterior segment and presents with varied manifestations impacting prognosis. Early diagnosis and prompt standard anti-syphilitic treatment can improve visual outcomes, although optic neuritis cases may have poorer prognosis. Monitoring for vitreous opacity and macular involvement is important for comprehensive management.

Conclusion

Ocular syphilis in HIV co-infected patients presents with diverse posterior segment manifestations and generally shows visual improvement after treatment. Optic neuritis is associated with worse visual prognosis, highlighting the need for tailored clinical attention.

References

  1. Pichi F et al. -- Classification of ocular syphilis manifestations
  2. Beijing You’an Hospital Study (2022-2025) -- Clinical features and outcomes of ocular syphilis with HIV

Original Source(s)

Related Content